Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
2.
Rev. méd. Chile ; 135(9): 1195-1201, sept. 2007.
Artículo en Español | LILACS | ID: lil-468211

RESUMEN

The use of antidepressant in depressive illness results in a reduction of suicidal attempts and deaths due to suicide, conditions that are generally present in this disorder. Recently, the Federal Drug Administration (FDA) prohibited the use of antidepressants during childhood and adolescence. This decision was based on a supposed increase in suicidal thinking in these age groups. However, the evidence came from flawed clinical studies, some of them not even published, in which no significant differences were observed when compared to placebo. It is not possible to ascribe a direct responsibility to antidepressants, because depression, by definition, has suicidal ideation. On the contrary, the reduction of suicidal rates supports the effectiveness of these medications.


Asunto(s)
Adolescente , Adulto , Niño , Humanos , Antidepresivos/efectos adversos , Trastorno Depresivo/tratamiento farmacológico , Suicidio/estadística & datos numéricos , United States Food and Drug Administration/legislación & jurisprudencia , Antidepresivos/uso terapéutico , Medicina Basada en la Evidencia , Placebos , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA